EDITORIAL

SARS-CoV-2 NAT+ donors for pediatric solid organ transplant recipients—Are they safe and provide good outcomes?

Corresponding Author

Ricardo M. La Hoz

[email protected]

orcid.org/0000-0002-1560-3192

Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA

Correspondence

Ricardo M. La Hoz, Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd. Dallas, TX 75390-9913, USA.

Email: [email protected]

Search for more papers by this author

Michael Green,

Michael Green

orcid.org/0000-0002-6011-2894

Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Pittsburgh School of Medicine, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA

Search for more papers by this author

Ricardo M. La Hoz,

Corresponding Author

Ricardo M. La Hoz

[email protected]

orcid.org/0000-0002-1560-3192

Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA

Correspondence

Ricardo M. La Hoz, Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd. Dallas, TX 75390-9913, USA.

Email: [email protected]

Search for more papers by this author

Michael Green,

Michael Green

orcid.org/0000-0002-6011-2894

Department of Pediatrics, Division of Pediatric Infectious Diseases, University of Pittsburgh School of Medicine, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA

Search for more papers by this author

First published: 04 October 2022

https://doi.org/10.1111/petr.14406

Citations: 2

Share a link

Email
Wechat
Bluesky

No abstract is available for this article.

CONFLICTS OF INTEREST

The authors of this manuscript have no conflicts of interest to disclose, as described by Pediatric Transplantation.

Open Research

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request.

REFERENCES

1Kwong AJ, Ebel NH, Kim WR, et al. OPTN/SRTR 2020 annual data report: liver. Am J Transplant. 2022; 22(Suppl. 2): 204-309.
10.1111/ajt.16978
PubMed Web of Science® Google Scholar
2La Hoz RM, Mufti AR, Vagefi PA. Short-term liver transplant outcomes from SARS-CoV-2 lower respiratory tract NAT positive donors. Transpl Infect Dis. 2022; 24(1):e13757.
10.1111/tid.13757
CAS PubMed Web of Science® Google Scholar
3Sanchez-Vivaldi JA, Patel MS, Shah JA, et al. Short-term kidney transplant outcomes from severe acute respiratory syndrome coronavirus 2 lower respiratory tract positive donors. Transpl Infect Dis. 2022; 24(4):e13890.
10.1111/tid.13890
CAS PubMed Web of Science® Google Scholar
4Goss MLD, Pouch S, Munoz-Rivas F, et al. A New Chapter in an Evolving Pandemic: Successful Pediatric Liver Transplantation with SARS-CoV-2+ Donors. Pediatr transplant pediaric transplantation; 2022.
Google Scholar
5Andersson MI, Arancibia-Carcamo CV, Auckland K, et al. SARS-CoV-2 RNA detected in blood products from patients with COVID-19 is not associated with infectious virus. Wellcome Open Res. 2020; 5: 181.
10.12688/wellcomeopenres.16002.2
PubMed Google Scholar
6Hanley B, Naresh KN, Roufosse C, et al. Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study. Lancet Microbe. 2020; 1(6): e245-e253.
10.1016/S2666-5247(20)30115-4
CAS PubMed Google Scholar
7Danziger-Isakov LGJ, Wooley A, Pouch S, et al. Organs from donors with positive SARS-CoV-2 NAT+ testing: a report from the ad hoc disease transmission advisory committee. Am J Transplant. 2022; 22(suppl 3).
Web of Science® Google Scholar
8Free RJ, Annambhotla P, La Hoz RM, et al. Risk of severe acute respiratory syndrome coronavirus 2 transmission through solid organ transplantation and outcomes of coronavirus disease 2019 among recent transplant recipients. Open forum. Infect Dis. 2022; 9(7):ofac221.
Web of Science® Google Scholar
9Goss MB, Galvan NTN, Ruan W, et al. The pediatric solid organ transplant experience with COVID-19: an initial multi-center, multi-organ case series. Pediatr Transplant. 2021; 25(3):e13868.
10.1111/petr.13868
CAS PubMed Web of Science® Google Scholar
10 Pediatrics AAo. Children and COVID-19: state-level data report. 2022; Available from: ervices.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-state-level-data-report/
Google Scholar
11Sapiano MRP, Jones JM, Bowman J, Levi ME, Basavaraju SV. Impact of US public health service increased risk deceased donor designation on organ utilization. Am J Transplant. 2019; 19(9): 2560-2569.
10.1111/ajt.15388
PubMed Web of Science® Google Scholar

Citing Literature

Volume26, Issue8

Special Issue:CLINICAL APPROACH TO PRACTICE VARIATION IN PEDIATRIC HEART TRANSPLANTATION

December 2022

e14406

SARS-CoV-2 NAT+ donors for pediatric solid organ transplant recipients—Are they safe and provide good outcomes?

CONFLICTS OF INTEREST

Open Research

DATA AVAILABILITY STATEMENT

REFERENCES

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

SARS-CoV-2 NAT+ donors for pediatric solid organ transplant recipients—Are they safe and provide good outcomes?

This article relates to:

A new chapter in an evolving pandemic: Successful pediatric liver transplantation with SARS-CoV-2+ donors

CONFLICTS OF INTEREST

Open Research

DATA AVAILABILITY STATEMENT

REFERENCES

Citing Literature

References

Related

Information